INTUNIV

This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, Finland, Ireland, Japan, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug INTUNIV contains one active pharmaceutical ingredient (API):

1 Guanfacine
UNII PML56A160O - GUANFACINE HYDROCHLORIDE

Guanfacine is a selective alpha2A-adrenergic receptor agonist in that it has 15-20 times higher affinity for this receptor subtype than for the alpha2B or alpha2C subtypes. Guanfacine is a non-stimulant. The mode of action of guanfacine in ADHD is not fully established.

Read about Guanfacine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
INTUNIV Prolonged-release tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C02AC02 Guanfacine C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AC Imidazoline receptor agonists
Discover more medicines within C02AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11440D, 11441E, 11451Q, 11452R
Country: CA Health Products and Food Branch Identifier(s): 02409100, 02409119, 02409127, 02409135
Country: EE Ravimiamet Identifier(s): 1697159, 1697160, 1697171, 1697182, 1697193, 1697216, 1697227, 1697238, 1697249
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1151040002, 1151040004, 1151040006, 1151040008
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 074927, 118421, 185859, 422340
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 310741, 310744, 310747, 310750
Country: IE Health Products Regulatory Authority Identifier(s): 21569, 21947, 23158, 24514, 55531
Country: JP 医薬品医療機器総合機構 Identifier(s): 1179057G1021, 1179057G2028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1078597, 1078598, 1078599, 1078600, 1078601, 1078602, 1078603, 1078604, 1078605
Country: NL Z-Index G-Standaard, PRK Identifier(s): 135321, 135348, 135356, 135364
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100090715, 100126175, 100157974, 100236001
Country: US FDA, National Drug Code Identifier(s): 54092-513, 54092-515, 54092-517, 54092-519

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.